Expressions of interest sought: Guideline on SGLT2 inhibitors and kidney disease
Expressions of interest are invited to produce clinical practice guidelines on SGLT2 inhibitors and kidney disease.
To apply please send a short statement of no more than one side of A4 explaining why you would like to be involved, along with a completed conflict of interest form to sarah.crimp@renal.org by Thursday 26 November 2020.
For review: Commentary on NICE guideline (NG136)
A draft Renal Association commentary on NICE guideline (NG136) ‘Hypertension in adults: diagnosis and management’ including proposals for blood pressure management in patients with chronic kidney disease is available for review.
Please send any comments using this form to Sarah Crimp by Thursday 26 November 2020.
For review: NICE methods of technology evaluation
The clinical practice guidelines invite Renal Association members to comment on the NICE public consultation that sets out the case for change to the methods it uses to develop guidance on medicines, medical devices and diagnostics. This will inform the responses of the Renal Association and the Royal College of Physicians.
To comment, please:
- Read the consultation document
- Complete the consultation comments form
- Email the consultation comments form to Sarah Crimp by Thursday 26 November 2020
